Allergy Research Laboratory, Carlos Haya Hospital, Málaga, Spain.
PLoS One. 2013;8(1):e53926. doi: 10.1371/journal.pone.0053926. Epub 2013 Jan 22.
Obeche wood dust is a known cause of occupational asthma where an IgE-mediated mechanism has been demonstrated.
To characterize the allergenic profile of obeche wood dust and evaluate the reactivity of the proteins by in vitro, ex vivo and in vivo assays in carpenters with confirmed rhinitis and/or asthma
An in-house obeche extract was obtained, and two IgE binding bands were purified (24 and 12 kDa) and sequenced by N-terminal identity. Specific IgE and IgG, basophil activation tests and skin prick tests (SPTs) were performed with whole extract and purified proteins. CCD binding was analyzed by ELISA inhibition studies.
Sixty-two subjects participated: 12 with confirmed occupational asthma/rhinitis (ORA+), 40 asymptomatic exposed (ORA-), and 10 controls. Of the confirmed subjects, 83% had a positive SPT to obeche. There was a 100% recognition by ELISA in symptomatic subjects vs. 30% and 10% in asymptomatic exposed subjects and controls respectively (p<0.05). Two new proteins were purified, a 24 kDa protein identified as a putative thaumatin-like protein and a 12 kDa gamma-expansin. Both showed allergenic activity in vitro, with the putative thaumatin being the most active, with 92% recognition by ELISA and 100% by basophil activation test in ORA+ subjects. Cross-reactivity due to CCD was ruled out in 82% of cases.
Two proteins of obeche wood were identified and were recognized by a high percentage of symptomatic subjects and by a small proportion of asymptomatic exposed subjects. Further studies are required to evaluate cross reactivity with other plant allergens.
奥贝克力木粉尘是职业性哮喘的已知病因,已证实其发病机制为 IgE 介导。
分析奥贝克力木粉尘的变应原特性,并通过体外、离体和体内试验评估其在确诊患有鼻炎和/或哮喘的木匠中的蛋白反应性。
提取奥贝克力木木内液,纯化 2 个 IgE 结合带(24 kDa 和 12 kDa),并通过 N 端鉴定进行测序。采用全提取物和纯化蛋白进行特异性 IgE 和 IgG、嗜碱性粒细胞激活试验和皮肤点刺试验(SPT)。采用 ELISA 抑制研究分析 CCD 结合。
共 62 名受试者参与:12 名确诊为职业性哮喘/鼻炎(ORA+),40 名无症状暴露(ORA-),10 名对照组。在确诊患者中,83%对奥贝克力木 SPT 呈阳性。在有症状患者中,ELISA 检测的识别率为 100%,而在无症状暴露患者和对照组中,分别为 30%和 10%(p<0.05)。纯化了两种新的蛋白,24 kDa 的蛋白被鉴定为一种潜在的甜蛋白,12 kDa 的蛋白被鉴定为一种γ-扩展蛋白。两种蛋白均在体外具有变应原活性,潜在的甜蛋白最为活跃,在 ORA+患者中,ELISA 检测的识别率为 92%,嗜碱性粒细胞激活试验的识别率为 100%。在 82%的病例中排除了因 CCD 引起的交叉反应。
鉴定出奥贝克力木的两种蛋白,被高比例的有症状患者和小部分无症状暴露患者所识别。需要进一步研究以评估与其他植物过敏原的交叉反应性。